Integer Holdings announced on 3 August that it has agreed to be acquired by investment funds managed by KKR in an all-cash transaction valued at roughly $5.7 billion in enterprise value. Integer is one of the largest contract development and manufacturing organizations in medical devices, making components for implantable cardiac, neurostimulation, vascular and orthopedic products. Deals like this one rarely make orthopedic headlines, but they should: a large share of the plates, screws and instruments that implant brands sell starts life on a contract manufacturer's machines.
The deal in numbers
- All-cash transaction with an enterprise value of approximately $5.7 billion.
- Integer stockholders receive $127 per share, a premium of about 51.8% to the closing price on 29 April 2026, the day before Integer announced a board-led strategic review.
- The deal was unanimously approved by Integer's board and is expected to close by the end of 2026, subject to stockholder and regulatory approval.
- Integer withdrew its financial outlook and cancelled the earnings call scheduled for 6 August.
- Goldman Sachs advised Integer; Centerview Partners, Barclays, Citi and Raymond James advised KKR.
Why a contract manufacturer matters to orthopedic buyers
Most orthopedic brands do not machine every implant they sell. Precision components — bone screws, plate blanks, instrument parts — come from a concentrated tier of contract manufacturers, and Integer sits near the top of that tier. When ownership of that tier consolidates under private equity, three things usually follow: capacity gets re-optimized toward the highest-margin product lines, pricing discipline tightens because financial owners run to margin targets, and smaller OEM customers lose priority to the largest accounts. None of this shows up in a hospital catalog, but all of it shows up in lead times.
The consolidation pattern across implant supply
The Integer deal continues a clear pattern in device manufacturing: private equity has been rolling up precision machining and component capacity for years, on the logic that aging populations guarantee procedure volume and that qualified capacity is hard to replicate. For orthopedic OEMs, fewer independent component suppliers mean less negotiating room. For hospitals and distributors downstream, the effect arrives as longer quoted lead times on made-to-order implants and occasional allocation on high-volume items like trauma screws and plating sets.
What this signals for trauma buyers
Three practical readings. First, supply-chain risk in implants now sits upstream, at the component tier, and it is consolidating — buyers should ask suppliers where their machining capacity comes from, not just where final assembly happens. Second, private-equity ownership cycles run four to seven years, so expect further reshuffling of this asset later in the decade rather than a stable new structure. Third, inventory strategy beats just-in-time ordering in this environment: distributor-held warehouse stock insulates a trauma program from upstream capacity games.
The BoneCraft angle
BoneCraft is an independent distributor of genuine orthopedic trauma implants. We watch manufacturing consolidation because it moves lead times before it moves headlines. Our model is built for exactly this environment: finished implants held in warehouse stock, ready to ship, with factory lot documentation intact. Contact our team for current availability across plates, nails and screws.
Sources
- Life Science Daily — Weekly News Roundup, 10 August 2026: Integer Holdings agrees to KKR acquisition
- Integer Holdings Investor Relations — definitive agreement announcement, 3 August 2026
- KKR News & Insights — acquisition announcement and fund details
Integer is a trademark of its respective owner. BoneCraft is an independent distributor of genuine orthopedic trauma implants and is not affiliated with, sponsored by, or endorsed by Integer Holdings, KKR or any other company mentioned.
-
BrandName Team
Process Media Manufacturer Since 2010
pproduces tower packing, molecular sieves, ceramic grinding media and other process media from our Pingxiang production base. We supply to industrial projects in over 100 countries.
